Drug profile · INN
sacubitril
ENTRESTO
- US status
- approved
- Patents linked
- 1
- News articles
- 0
Quick answer
sacubitril (ENTRESTO) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN sacubitril
Brand ENTRESTO
Route ORAL
Formulation CAPSULE, PELLETS
ATC code C09DX04
Related patents
Search patents →Frequently asked questions
What is sacubitril?
sacubitril (ENTRESTO) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for sacubitril?
ENTRESTO is a marketed brand name for sacubitril. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sacubitril?
sacubitril has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.